Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akira, S. (2003). Mammalian Toll-like receptors. Curr. Opin. Immunol. 15: 5–11.
Aratani, Y., Kura, F., Watanabe, H., Akagawa, H., Takano, Y., Suzuki, K., Dinauer, M.C., Maeda, N., and Koyama, H. (2002). Relative contribution of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus. Med. Mycol. 40: 557–563.
Ashman, R.B. (1998). Candida albicans: Pathogenesis, immunity and host defence. Res. Immunol. 149: 281–288.
Bacci, A., Montagnoli, C., Perruccio, K., Bozza, S., Gaziano, R., Pitzurra, L., Velardi, A., d’Ostiani, C.F., Cutler, J.E., and Romani, L. (2002). Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J. Immunol. 168: 2904–2913.
Belanger, P.H., Johnston, D.A., Fratti, R.A., Zhang, M., and Filler, S.G. (2002). Endocytosis of Candida albicans by vascular endothelial cells is associated with tyrosine phosphorylation of specific host cell proteins. Cell. Microbiol. 4: 805–812.
Bellocchio, S. Montagnoli, C., Bozza, S., Gaziano, R., Rossi, G., Mambula, S.S., Vecchi, A., Mantovani, A., Levitz, S.M., and Romani, L. (2004). The contribution of the Toll-like receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 172: 3059–3069.
Bodey, G. P., Buckley, M., Sathe, Y. S., and Freireich, E. J. (1966). Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med. 64: 328–340.
Bogdan, C., Rollinghoff, M., and Diefenbach, A. (2000). Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12: 64–76.
Bohme, A., Karthaus, M., and Hoelzer, D. (1999). Antifungal prophylaxis in neutropenic patients with hematologic malignancies: Is there a real benefit? Chemotherapy 45: 224–232.
Bozza, S., Montagnoli, C., Gaziano, R., Rossi, G., Nkwanyuo, G., Bellocchio, S., and Romani, L. (2003). Dendritic cell-based vaccination against opportunistic fungi. Vaccine 22: 857–864.
Bromuro, C., Torosantucci, A., Chiani, P., Conti, S., Polonelli, L., and Cassone, A. (2002). Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect. Immun. 70: 5462–5470.
Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M., and Zanovello, P. (2003). l-Arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 24: 302–306.
Brown, A.J. (2002). Expression of growth form-specific factors during morphogenesis in Candida albicans. In R.A. Calderone (ed.), Candida and Candidiasis. ASM Press, Washington, DC, pp. 87–106.
Brown, G.D., Herre, B., William, D.L., Willment, J.A., Marshall, A.S., and Gordon, S. (2003). Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197: 1119–1124.
Buentke, E. and Scheynius, A. (2003). Dendritic cells and fungi. APMIS 111: 789–796.
Calderone, R.A. (eds.) Candida and Candidiasis. ASM Press, Washington, DC, 2002.
Calderone, R. (1994). Molecular pathogenesis of fungal infections. Trends Microbiol. 2: 461–463.
Cambi, A., Gijzen, K., de Vries, J.M., Torensma, R., Joosten, B., Adema, G.J., Netea, M.G., Kullberg, B.J., Romani, L., and Figdor, C.G. (2003). The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 33: 532–538.
Casadevall, A., Feldmesser, M., and Pirofski, L.-A. (2002). Induced humoral immunity and vaccination against major human fungal pathogens. Curr. Opin. Microbiol. 5: 386–391.
Cenci, E., Mencacci, A., Del Sero, G., Bistoni, F., and Romani L. (1997). Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. J. Infect. Dis. 176: 217–226.
Chauhan, N., Inglis, D., Roman, E., Pla, J., Li, D., Calera, J.A., and Calderone, R. (2003). Candida albicans response regulator gene SSK1 regulates a subset of genes whose functions are associated with cell wall biosynthesis and adaptation to oxidative stress. Eukaryot. Cell. 2: 1018–1024.
Cheng, V.C., Yuen, K.Y., Chan, W.M., Wuong, S.S., Ma, E.S., and Chan, R.M. (2000). Immunorestitution disease involving the innate and adaptive response. Clin. Infect. Dis. 30: 882–892.
Chiani, P., Bromuro, C., and Torosantucci, A. (2000). Defective induction of interleukin-12 in human monocytes by germ-tube forms of Candida albicans. Infect. Immun. 68: 5628–5634.
Choi, E.H., Foster, C.B., Taylor, J.G., Erichsen, H.C., Chen, R.A., Walsh, T.J., Anttila, V.J., Ruutu, T., Palotie, A., and Chanock, S.J. (2003). Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J. Infect. Dis. 187: 1153–1156.
Claudia, M., Bacci, A., Silvia, B., Gaziano, R., Spreca, A., and Romani, L. (2002). The interaction of fungi with dendritic cells: Implications for TH immunity and vaccination. Curr. Mol. Med. 2: 507–524.
Cotter, G., Doyle, S., and Kavanagh, K. (2000). Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol. Med. Microbiol. 27: 163–169.
Coste, A., Duboourdeau, M., Linas, M.D., Cassaing, S., Lepert, J.C., Balard, P., Chalmeton, S., Bernard, J., Orfila, C., Seguela, J.P., and Pipy, B. (2003). PPARgamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. Immunity 19: 329–339.
Cutler, J.E., Granger, B.L., and Han, Y. (2002). Immunoprotection against Candidiasis. In R.A. Calderone (ed.), Candida and Candidiasis. ASM press, Washington DC:, pp. 243–256.
Fearon, D.T. and Locksley, R.M. (1996). The instructive role of innate immunity in the acquired immune response. Science 272: 50–53.
Fè d’Ostiani, C., Del Sero, G., Bacci, A., Montagnoli, C., Spreca, A., Mencacci, A., Ricciardi-Castagnoli, P., and Romani, L. (2000). Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191: 1661–1674.
Fidel, P. L., Jr. and Sobel, J. D. (1994). The role of cell-mediated immunity in candidiasis. Trends Microbiol. 6: 202–206.
Gantner, B.N., Simmons, R.M., Canavera, S.J., Akira, S., and Underhill, D.M. (2003). Collaborative induction of inflammatory responses by Dectin-1 and Toll-like receptor 2. J. Exp. Med. 197: 1107–1117.
Geiger, J., Wessels, D., Lockhart, S.R., and Soll, D.R. (2004). Release of a potent polymorphonuclear leukocyte chemoattractant is regulated by white-opaque switching in Candida albicans. Infect. Immun. 72: 667–677.
Georgopapadakou, N.H. and Walsh, T.J. (1996). Antifungal agents: Chemotherapeutic targets and immunologic strategies. Antimicrob. Agents Chemother. 40: 279–291.
Gor, D.O., Rose, N.R., and Greenspan, N.S. (2003). TH1-TH2: A procustean paradigm. Nat. Immunol. 4: 503–505.
Gow, N.A., Brown, A.J., and Odds, F.C. (2002). Fungal morphogenesis and host invasion. Curr. Opin. Microbiol. 5: 366–371.
Hamilton, A.J. and Holdon, M.D. Antioxidant systems in the pathogenic fungi of man and their role in virulence. Med. Mycol. 37: 375–389.
Han, Y., Kozel, T.R., Zhang, M.X., MacGill, R.S., and Carroll, M.C. (2001). Complement is essential for protection by an IgM and IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J. Immunol. 167: 1550–1557.
Herring, A.C. and Huffnagle, G.B. (2001). Innate immunity to fungi. In S.H.E. Kaufmann, A. Sher, and R. Ahmed (eds), Immunology of Infectious Diseases. ASM Press, Washington, DC, pp. 127–137.
Hoffmann, J.A. and Reichhart, J.M. (2002). Drosophila innate immunity: An evolutionary perspective. Nat. Immunol. 3: 121–126.
Huang, Q., Liu, D., Majewski, P., Schulte, L.C., Korn, J.M., Young, R.A., Lander, E.S., and Hacohen, N. (2001). The plasticity of dendritic cell responses to pathogens and their components. Science 294: 870–875.
Ibata-Ombetta, S., Idziorek, T., Trinel, P.A., Poulain, D., and Jouault, T. (2003). Candida albicans phospholipomannan promotes survival of phagocytosed yeasts through modulation of bad phosphorylation and macrophage apoptosis. J. Biol. Chem. 278: 13086–13093.
Jarvis, W.R. (1995). Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20: 1526–1530.
Jones-Carson, J., Vazquez-Torres, A., van der Heyde, H.C., Warner, T., Wagner, R.D., and Balish, E. (1995). Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat. Med. 1: 552–557.
Jouault, T., Ibata-Ombetta, S., Takeuchi, O., Trinel, P.A., Sacchetti, P., Lefebvre, P., Akira, S., and Poulain, D. (2003). Candida albicans phospholipomannan is sensed through Toll-like receptors. J. Infect. Dis. 188: 165–172.
Kaposzta, R., Marodi, L., Hollinshead, M., Gordon, S., and da Silva R.P. (1999). Rapid recruitment of late endosomes and lysosomes in mouse macrophages ingesting Candida albicans. J. Cell Sci. 112: 3237–3248.
Kozel, T.R. (1998). Complement activation by pathogenic fungi. Res. Immunol. 149: 309–320.
Kozel, T.R., MacGill, R.S., Percival, A., and Zhou, Q. (2004). Biological activities of naturally occurring antibodies reactive with Candida albicans mannan. Infect. Immun. 72: 209–218.
Kullberg, B., Vogels, M.T.E., and van der Meer, J.W.M. (1994). Immunomodulators in bacterial and fungal infections. A review of their therapeutic potential. Clin. Immunother. 1: 43–55.
Kullberg, B.J. and Anaissie, E.J. (1998). Cytokines as therapy for opportunistic fungal infections. Res. Immunol. 149: 478–488.
Lan, C.Y., Newport, G., Murillo, L.A., Jones, T., Scherer, S., Davis, R.W., and Agabian, N. (2002). Metabolic specialization associated with phenotypic switching in Candida albicans. Proc. Natl. Acad. Sci. USA 99: 14907–14912.
La Sala, A., Urbani, F., Torosantucci, A., Cassone, A., and Ausiello, C. (1996). Mannoproteins from Candida albicans elicit a Th1-type-1 cytokine profile in human Candida specific long-term T cell cultures. J. Biol. Regul. Homeost. Agents 10: 8–12.
La Valle, R., Sandini, S., Gomez, M.J., Mondello, F., Romagnoli, G., Nisini, R., and Cassone, A. (2000). Generation of a recombinant 65-kilodalton mannoprotein, a major antigen target of cell-mediated immune response to Candida albicans. Infect. Immun. 68: 6777–6784.
Letterio, J.J., Lehrnbecher, T., Pollack, G., Walsh, T.J., and Chanock, S.J. (2001). Invasive candidiasis stimulates hepatocyte and monocyte production of active transforming growth factor beta. Infect. Immun. 69: 5115–5120.
Lilic, D. (2002). New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr. Opin. Infect. Dis. 15: 143–147.
Lilic, D., Gravenor, I., Robson, N., Lammas, D.A., Drysdale, P., Calvert, J.E., Cant, A.J., and Abinum, M. (2003). Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect. Immun. 71: 5690–5699.
Liston, A., Lesage, S., Wilson, J., Peltonen, L., and Goodnow, C. C. (2003). Air regulates negative selection of organ-specific T cells. Nat. Immunol. 4: 350–435.
Liu, L., Kang, K., Takahara, M., Cooper, K.D., and Ghannoum, M.A. (2001). Hyphae and yeasts of Candida albicans differentially regulate interleukin-12 production by human blood monocytes: Inhibitory role of C. albicans germination. Infect. Immun. 69: 4695–4697.
Lorenz, M.C. and Fink, G.R. (2001). The glyoxylate cycle is required for fungal virulence. Nature 412: 83–86.
Magliani, W., Conti, S., de Bernardis, F., Gerloni, M., Bertolotti, D., Mozzoni, P., Cassone, A., and Polonelli, L. (1997). Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 15: 155–158.
Magliani, W., Conti, S., Arseni, S., Frazzi, R., Salati, A., and Polonelli, L. (2001). Killer anti-idiotypes in the control of fungal infections. Curr. Opin. Investig. Drugs 2: 477–479.
Mansour, M.K. and Levitz, S.M. (2002). Interactions of fungi with phagocytes. Curr. Opin. Microbiol. 5: 359–365.
Marodi, L. (2002). Deficient interferon-gamma receptor-mediated signalling in neonatal macrophages. Acta Paediatr. Suppl. 91: 117–119.
Marodi, L., Schreiber, S., Anderson, D.C., MacDermott, R.P., Korchak, H.M., and Johnston, R.B. Jr. (1993). Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Invest. 91: 2596–2601.
Marquis, G., Garzon, S., Montplaisir, S., Strykowski, H., and Benhamou, N. (1991). Histochemical and immunochemical study of the fate of Candida albicans inside human neutrophil phagolysosomes. J. Leukoc. Biol. 50: 587–599.
Marr, K.A., Balajee, S.A., Hawn, T.R., Ozinsky, A., Pham, U., Akira, S., Aderem, A., and Liles, W.C. (2003). Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect. Immun. 71: 5280–5286.
Matthews, R. and Burnie, J. (2001). Antifungal antibodies: A new approach to the treatment of systemic candidiasis. Curr. Opin. Investig. Drugs 2: 472–476.
McKnight, A. and Gordon, S. (2000). Forum in Immunology: Innate recognition systems. Microbes Infect. 2: 239–336.
Medzhitov, R. and Janeway, C.A. Jr. (1997). Innate immunity: The virtues of a nonclonal system of recognition. Cell 91: 295–298.
Mencacci, A., Bacci, A., Cenci, E., Montagnoli, C., Fiorucci, S., Casagrande, A., Flavell, R.A., Bistoni, F., and Romani, L. (2000). Interleukin-18 restores detective Th1 immunity to Candida albicans in caspase 1-deficient mice. Infect. Immun. 68: 5126–5131.
Mencacci, A., Cenci, E., Bacci, A., Bistoni, F., and Romani, L. (2000). Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis. J. Infect. Dis. 181: 686–694.
Mencacci, A., Perruccio, K., Bacci, A., Cenci, E., Benedetti, R., Martelli, M. F., Bistoni, F., Coffman, R., Velardi, A., and Romani, L. (2001). Defective antifungal T-helper 1 (TH1) immunity a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. Blood 97: 1483–1490.
Mencacci, A., Montagnoli, C., Bacci, A., Cenci, E., Pitzurra, L., Spreca, A., Kopf, M., Sharpe, A.H., and Romani, L. (2002). CD80+Gr-1+ myeloid cells inhibit development of antifungal TH1 immunity in mice with candidiasis. J. Immunol. 169: 3180–3190.
Millar, D.G., Garza, K.M., Odermatt, B., Elford, A.R., Ono, N., Li, Z., and Ohashi, P.S. (2003). HPS70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat. Med. 9: 1469–1476.
Miller, M.G. and Johnson, A.D. (2002). White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell 110: 293–302.
Montagnoli, C., Bacci, A., Bozza, S., Gaziano, R., Mosci, P., Sharpe, H.A., and Romani, L. (2002). B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory protective immunity to Candida albicans. J. Immunol. 169: 6298–6308.
Montagnoli, C., Bozza, S., Bacci, A., Gaziano, R., Mosci, P., Morschhauser, J., Pitzurra, L., Kopf, M., Cutler, J., and Romani, L. (2003). A role for antibodies in the generation of memory antifungal immunity. Eur. J. Immunol. 33: 1193–1204.
Mullick, A., Elias, M., Harakidas, P., Marcil, A., Whiteway, M., Ge, B., Hudson, T.J., Caron, A.W., Bouget, L., Picard, S., Jovcevski, O., Massie, B., and Thomas, D.Y. (2004). Gene expression in HL60 granulocytoid and human polymorphonuclear leukocytes exposed to Candida albicans. Infect. Immun. 72: 414–429.
Nantel, A., Dignard, D., Bachewich, C., Harcus, D., Marcil, A., Bouin, A.P., Sensen, C.W., Hogues, H., van het Hoog, M., Gordon, P., et al. (2002). Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition. Mol. Biol. Cell. 13: 3452–3465.
Newman, S.L. and Holly, A. (2001). Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect. Immun. 69: 6813–6822.
O’Neill, L.A., Fitzgerald, K.A., and Bowie, A.G. (2003). The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24: 286–290.
Netea, M.G., Stuyt, R. J., Kim, S.H., Van der Meer, J.W., Kullberg, B.J., and Dinarello, C.A. (2002a). The role of endogenous interleukin (IL)-18, IL-12, IL-1β, and tumor necrosis factor-α in the production of interferon-γ induced by Candida albicans in human whole-blood cultures. J. Infect. Dis. 185: 963–970.
Netea, M.G., Van Der Graaf, C.A., Vonk, A.G., Verschueren, I, Van Der Meer, J.W., and Kullberg, B.J. (2002b). The role of Toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 185: 1483–1489.
Netea, M.G., vonk, A.G., van den Hoven, M., Verschueren, I., Joosten, L.A., van Krieken, J.H., van den Berg., Van deer Meer, J.W., and Kullberg, B.J. (2003). Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection. Eur. J. Immunol. 33: 3409–3417.
Pasare, C. and Medzhitov, R. (2003). Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033–1036.
Polonelli, L., Magliani, W., Conti, S., Bracci, L., Lozzi, L., Neri, P., Adriani, D., De Bernardis, F., and Cassone, A. (2003). Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect. Immun. 71: 6205–6212.
Poynton, H.C. (1997). Immune modulation by cytokines in the treatment of opportunistic infections. Curr. Opin. Infect. Dis. 10: 275–280.
Poynton, C.H., Barnes, R.A., and Rees, J. (1998). Interferon γ and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia. Clin. Inf. Dis. 26: 239–240.
Puccetti, P., Romani, L., and Bistoni, F. (1995). A TH1-TH2-like switch in candidiasis: New perspectives for therapy. Trends Microbiol. 3: 237–240.
Raveh, D., Kruskal, B.A., Farland, J., and Ezekowitz, R.A. (1998). Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J. Leukoc. Biol. 64: 108–113.
Read, S. and Powrie, F. (2001). CD4+ regulatory T cells. Curr. Opin. Immunol. 13: 644–649.
Rodriguez-Adrian, L.J., Grazziutti, M.L., Rex, H.J., and Anaissie, E.J. (1998). The potential role of cytokine for fungal infections in patients with cancer: Is recovery from neutropenia all that is needed? Clin. Infect. Dis. 26: 1270–1278.
Roeder, A., Kirscning, C.J., Rupec, R.A., Schaller, M., and Korting, H.C. (2004). Toll-like receptors and innate antifungal responses. Trends Microbiol. 12: 44–49.
Roilides, E., Sein, T., Schaufele, R., Chanock, S.J., and Walsh, T.J. (1998). Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis. J. Infect. Dis. 178: 589–592.
Roilides, E., Lamaignere, C.G., and Farmaki, E. (2002). Cytokines in immunodeficient patients with invasive fungal infections: An emerging therapy. Int. J. Infect. Dis. 6: 154–163.
Romagnoli, G., Nisini, R., Chiani, P., Mariotti, S., Teloni, R., Cassone, A., and Torosantucci, A. (2004). The interaction of human dendritic cells with yeasts and germ-tube forms of Candida albicans leads to efficient fungal processing, dendritic cell maturation, and acquisition of a Th1 response-promoting function. J. Leukoc. Biol. 75: 117–126.
Romani, L. (2004). Immunity to fungal infections. Nat. Rev. Immunol. 4: 11–23.
Romani, L. (2002). Innate immunity against fungal pathogens. In R.A. Calderone and L.R. Cihlar (eds), Fungal Pathogenesis. Principles and Clinical Applications. Marcel Dekker, New York, pp. 401–432.
Romani, L. (2003). Cytokines in the innate and adaptive immunity to Candida albicans. In M. Kotb and T. Calandra (eds), Cytokines and Chemokines in Infectious Diseases Handbook. Humana Press, Totowa, NJ, pp. 227–241.
Romani, L. (1999). Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2: 363–367.
Romani, L., Montagnoli, C., Bozza, S., Perruccio, K., Spreca, A., Allavena, P., Verbeek, S., Calderone, R.A., Bistoni, F., and Puccetti, P. (2004). The exploitation of distinct recognition receptors in dendritic cells determines the full range of host’s immune relationships with Candida albicans. Int. Immunol. 16: 149–161.
Romani, L., Bistoni, F., and Puccetti, P. (2003). Adaptation of Candida albicans to the host environment: The role of morphogenesis in virulence and survival in mammalian hosts. Curr. Opin. Microbiol. 6: 338–343.
Romani, L., Bistoni, F., and Puccetti, P. (2002). Fungi, dendritic cells and receptors: A host perspective of fungal virulence. Trends Microbiol. 10: 508–514.
Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Toniatti, C., Puccetti, P., Bistoni, F., and Poli, V. (1996). Impaired neutrophil response and CD4+ T helper cell 1 development in inter-leukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183: 1345–1355.
Rooney, P.J. and Klein, B.S. (2002). Linking fungal morphogenesis with virulence. Cell. Microbiol. 4: 127–137.
Sanchez, A.A., Johnston D.A., Myers, C., Edwards, J.E. Jr., Mitchell, A.P., and Miller, S.G. (2004). Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect. Immun. 72: 598–601.
Schroppel, K., Kryk, M., Herrmann, M., Leberer, E., Rollinghoff, M., and Bogdan, C. (2001). Suppression of type 2 NO-synthase activity in macrophages by Candida albicans. Int. Med. Microbiol. 290: 659–668.
Soll, D.R. (2002). Candida commensalism and virulence: The evolution of phenotypic plasticity. Acta Trop. 81: 101–110.
Spellberg, B., Johnston, D., Phan, Q.T., Edwards, J.E., French, S.W., Ibrahim, A.S., and Filler, S.G. (2003). Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis. Infect. Immun. 71: 5756–5764.
Steinman, R.M. and Pope, M. (2002). Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 109: 1519–1526.
Stevens, D.A. (1998). Combination immunotherapy and antifungal chemotherapy. Clin. Infect. Dis. 26: 1266–1269.
Stevens, D.A., Walsh, T.J., Bistoni, F., Cenci, E., Clemons, K.V., Del Sero, G., Fè d’Ostiani, C., Kullberg, B.J., Mencacci, A., Roilides, E., and Romani, L. (1998). Cytokines and mycoses. Med. Mycol. 36(S1): 174–182.
Stuyt, R.J., Netea, M.G., Verschueren, I., Fantuzzi, G., Dinarello, C.A., Van Der Meer, J.W., and Kullberg, B.J. (2002). Role of inter-leukin-18 in host defense against disseminated Candida albicans infection. Infect. Immun. 70: 3284–3286.
Tada, H., Nemoto, E., Shimauchi, H., Watanabe, T., Mikami, T., Matsumoto, T., Ohno, N., Tamura, H., Shibata, K., Akashi, S., Miyake, K., Sugawara, S., and Takada, H. (2002). Saccharomyces cerevisiae-and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14-and Toll-like receptor 4-dependent manner. Microbiol. Immunol. 46: 503–512.
Torosantucci, A., Chiani, P., De Bernardis, F., Cassone, A., Calera, J.A., and Calderone, R. (2002). Deletion of the two-component histidine kinase gene (CHK1) Candida albicans contributes to enhanced growth inhibition and killing by human neutrophils in vitro. Infect. Immun. 70: 985–987.
Torosantucci, A., Romagnoli, G., Chiani, P., Stringaro, A., Crateri, P., Mariotti, S., Teloni, R., Arancia, G., Cassone, A., and Nisini, R. (2004). Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: A novel dimorphism-dependent mechanism to escape the host’s immune response. Infect. Immun. 72: 833–843.
van Spriel, A.B., van den Herik-Oudijk, I.E., van Sorge, N.M., Vile, H.A., van Strijp, J.A., and van de Winkel, J.G. (1999). Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils. J. Infect. Dis. 179: 661–669.
van Spriel, A.B., Leuse, J.H.W., van Egmond, M., Dijkman, H.B.P.M., Assmann, K.J.M., Mayadas, T.N., and van de Winkel, J.G. (2001). Mac-1 (CD11b/Cd18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood 97: 2478–2486.
Vasquez-Torres, A. and Balish, E. (1997). Macrophages in resistance to candidiasis. Microbiol. Mol. Rev. 61: 170–192.
Villamon, E., Gozalbo, D., Roig, P., O’Connor, J.E., Fradelizi, D., and Gil, M.L. (2004). Tolllike receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect. 6: 1–7.
Walsh, T.J., Hiemenz, J., and Pizzo, P.A. (1994). Evolving risk factors for invasive fungal infections-all neutropenic patients are not the same. Clin. Infect. Dis. 18: 793–798.
Wanten, G.J., Netea, M.G., Naber, T.H., Curfs, J.H., Jacobs, L.E., Verver-Jansen, T.J., and Kullberg, B.J. (2002). Parenteral administration of medium-but not long-chain lipid emulsions may increase the risk for infections by Candida albicans. Infect. Immun. 70: 6471–6474.
Wellington, M., Bliss, J.M., and Haidaris, C.G. (2003). Enhanced phagocytosis of Candida species mediated by opsonization with a recombinant human antibody single-chain variable fragment. Infect. Immun. 71: 7228–7231.
Yamamoto, M., et al. (2003). Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301: 640–643.
Yamamoto, Y., Specter, S., and Friedman, H. (1993). Lipopolysaccharide restores anti-Candida albicans growth inhibition activity of polymorphonuclear neutrophils from retrovirus-immunosuppressed mice. Infect. Immun. 61: 2216–2219.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Romani, L. (2005). Innate and Adaptive Immunity to Systemic Candida albicans Infection. In: Fidel, P.L., Huffnagle, G.B. (eds) Fungal Immunology. Springer, Boston, MA. https://doi.org/10.1007/0-387-25445-5_19
Download citation
DOI: https://doi.org/10.1007/0-387-25445-5_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24092-3
Online ISBN: 978-0-387-25445-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)